drugset / Trial / NCT04462666

Oral Huzhang Granules for Acute Gouty Arthritis

NCT04462666

Phase 2 Unknown 267 enrolled Shanghai Yueyang Integrated Medicine Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

We designed this study as a double-blind, randomized, controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of acute gouty arthritis

Timeline

Start
2020-07-01
Primary completion
2023-07-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Chinese herbal medicine Traditional medicine (herbal / TCM) 1 unknown Oral
Comparator Etoricoxib Small molecule 1 unknown Oral

Indications